Doximity, Inc. (DOCS)

$23.91

-0.67

(-2.73%)▲

Market is closed - opens 7 PM, 25 Apr 2024

Insights on Doximity, Inc.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 108.46M → 135.28M (in $), with an average increase of 10.3% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 28.40M → 47.95M (in $), with an average increase of 21.7% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 48.1% return, outperforming this stock by 79.2%

Performance

  • $23.84
    $24.76
    $23.91
    downward going graph

    0.29%

    Downside

    Day's Volatility :3.7%

    Upside

    3.41%

    downward going graph
  • $19.71
    $36.92
    $23.91
    downward going graph

    17.57%

    Downside

    52 Weeks Volatility :46.61%

    Upside

    35.24%

    downward going graph

Returns

PeriodDoximity, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-19.66%
1.7%
0.0%
6 Months
9.88%
11.3%
0.0%
1 Year
-31.13%
5.4%
1.3%
3 Years
-54.89%
13.9%
-22.1%

Highlights

Market Capitalization
4.6B
Book Value
$4.64
Earnings Per Share (EPS)
0.67
PE Ratio
36.69
PEG Ratio
2.97
Wall Street Target Price
29.69
Profit Margin
29.39%
Operating Margin TTM
43.61%
Return On Assets TTM
9.91%
Return On Equity TTM
15.34%
Revenue TTM
468.3M
Revenue Per Share TTM
2.44
Quarterly Revenue Growth YOY
17.4%
Gross Profit TTM
365.6M
EBITDA
169.9M
Diluted Eps TTM
0.67
Quarterly Earnings Growth YOY
0.5
EPS Estimate Current Year
0.9
EPS Estimate Next Year
0.95
EPS Estimate Current Quarter
0.23
EPS Estimate Next Quarter
0.2

Analyst Recommendation

Buy
    43%Buy
    43%Hold
    13%Sell
Based on 23 Wall street analysts offering stock ratings for Doximity, Inc.(by analysts ranked 0 to 5 stars)
Based on 23 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
14
Hold
10
9
6
Sell
3
3
3

Analyst Forecast

What analysts predicted

Upside of 24.17%

Current $23.91
Target $29.69

Company Financials

FY19Y/Y Change
Revenue
85.7M
-
Net Income
7.8M
-
Net Profit Margin
9.14%
-
FY20Y/Y Change
Revenue
116.4M
↑ 35.82%
Net Income
29.7M
↑ 279.64%
Net Profit Margin
25.55%
↑ 16.41%
FY21Y/Y Change
Revenue
206.9M
↑ 77.76%
Net Income
50.2M
↑ 68.85%
Net Profit Margin
24.27%
↓ 1.28%
FY22Y/Y Change
Revenue
343.5M
↑ 66.05%
Net Income
154.8M
↑ 208.27%
Net Profit Margin
45.05%
↑ 20.78%
FY23Y/Y Change
Revenue
419.1M
↑ 21.98%
Net Income
112.8M
↓ 27.11%
Net Profit Margin
26.92%
↓ 18.13%
Q3 FY22Q/Q Change
Revenue
102.2M
↑ 12.74%
Net Income
26.3M
↑ 17.5%
Net Profit Margin
25.74%
↑ 1.05%
Q4 FY22Q/Q Change
Revenue
115.3M
↑ 12.8%
Net Income
33.5M
↑ 27.26%
Net Profit Margin
29.04%
↑ 3.3%
Q1 FY23Q/Q Change
Revenue
111.0M
↓ 3.73%
Net Income
30.7M
↓ 8.37%
Net Profit Margin
27.64%
↓ 1.4%
Q2 FY23Q/Q Change
Revenue
108.5M
↓ 2.25%
Net Income
28.4M
↓ 7.38%
Net Profit Margin
26.19%
↓ 1.45%
Q3 FY23Q/Q Change
Revenue
113.6M
↑ 4.74%
Net Income
30.6M
↑ 7.73%
Net Profit Margin
26.94%
↑ 0.75%
Q4 FY23Q/Q Change
Revenue
135.3M
↑ 19.08%
Net Income
48.0M
↑ 56.71%
Net Profit Margin
35.45%
↑ 8.51%
FY19Y/Y Change
Total Assets
86.6M
-
Total Liabilities
37.8M
-
FY20Y/Y Change
Total Assets
138.9M
↑ 60.49%
Total Liabilities
137.8M
↑ 264.43%
FY21Y/Y Change
Total Assets
251.7M
↑ 81.2%
Total Liabilities
185.0M
↑ 34.25%
FY22Y/Y Change
Total Assets
991.4M
↑ 293.83%
Total Liabilities
112.8M
↓ 39.04%
FY23Y/Y Change
Total Assets
1.1B
↑ 14.68%
Total Liabilities
170.8M
↑ 51.44%
Q3 FY22Q/Q Change
Total Assets
1.0B
↓ 2.15%
Total Liabilities
149.4M
↑ 0.41%
Q4 FY22Q/Q Change
Total Assets
1.1B
↑ 3.77%
Total Liabilities
136.9M
↓ 8.35%
Q1 FY23Q/Q Change
Total Assets
1.1B
↑ 6.54%
Total Liabilities
170.8M
↑ 24.73%
Q2 FY23Q/Q Change
Total Assets
1.2B
↑ 1.46%
Total Liabilities
162.7M
↓ 4.71%
Q3 FY23Q/Q Change
Total Assets
1.0B
↓ 11.09%
Total Liabilities
154.1M
↓ 5.3%
Q4 FY23Q/Q Change
Total Assets
1.0B
↓ 2.43%
Total Liabilities
136.0M
↓ 11.73%
FY19Y/Y Change
Operating Cash Flow
15.3M
-
Investing Cash Flow
-9.1M
-
Financing Cash Flow
985.0K
-
FY20Y/Y Change
Operating Cash Flow
26.2M
↑ 71.17%
Investing Cash Flow
-13.1M
↑ 44.42%
Financing Cash Flow
1.7M
↑ 74.52%
FY21Y/Y Change
Operating Cash Flow
83.0M
↑ 216.7%
Investing Cash Flow
-70.4M
↑ 437.74%
Financing Cash Flow
5.4M
↑ 214.54%
FY22Y/Y Change
Operating Cash Flow
126.6M
↑ 52.55%
Investing Cash Flow
-640.6M
↑ 809.69%
Financing Cash Flow
560.4M
↑ 10264.62%
FY23Y/Y Change
Operating Cash Flow
179.6M
↑ 41.89%
Investing Cash Flow
-59.9M
↓ 90.65%
Financing Cash Flow
-74.5M
↓ 113.29%
Q3 FY22Q/Q Change
Operating Cash Flow
39.5M
↓ 11.7%
Investing Cash Flow
-18.5M
↓ 55.37%
Financing Cash Flow
-57.4M
↑ 861.79%
Q4 FY22Q/Q Change
Operating Cash Flow
48.7M
↑ 23.24%
Investing Cash Flow
13.3M
↓ 171.82%
Financing Cash Flow
779.0K
↓ 101.36%
Q1 FY23Q/Q Change
Operating Cash Flow
46.6M
↓ 4.23%
Investing Cash Flow
-13.2M
↓ 199.25%
Financing Cash Flow
-11.9M
↓ 1622.72%
Q2 FY23Q/Q Change
Operating Cash Flow
57.2M
↑ 22.64%
Investing Cash Flow
117.3M
↓ 988.56%
Financing Cash Flow
-25.8M
↑ 117.7%
Q3 FY23Q/Q Change
Operating Cash Flow
12.9M
↓ 77.45%
Investing Cash Flow
-50.1M
↓ 142.7%
Financing Cash Flow
-161.1M
↑ 523.92%

Technicals Summary

Sell

Neutral

Buy

Doximity, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Doximity, Inc.
Doximity, Inc.
-11.15%
9.88%
-31.13%
-54.89%
-54.89%
Solventum Corp
Solventum Corp
-8.05%
-8.05%
-8.05%
-8.05%
-8.05%
Veeva Systems Inc.
Veeva Systems Inc.
-12.6%
2.95%
12.12%
-29.27%
46.25%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-1.77%
34.43%
7.87%
43.36%
43.36%
Healthequity Inc
Healthequity Inc
-0.23%
9.82%
48.12%
3.76%
13.86%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Doximity, Inc.
Doximity, Inc.
36.69
36.69
2.97
0.9
0.15
0.1
NA
4.64
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.45
62.45
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.44
28.44
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
124.8
124.8
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Doximity, Inc.
Doximity, Inc.
Buy
$4.6B
-54.89%
36.69
29.39%
Solventum Corp
Solventum Corp
NA
$11.7B
-8.05%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.4B
46.25%
62.45
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.4B
43.36%
28.44
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
13.86%
124.8
5.57%

Institutional Holdings

  • Vanguard Group Inc

    5.84%

  • BlackRock Inc

    5.65%

  • Morgan Stanley - Brokerage Accounts

    3.76%

  • Baillie Gifford & Co Limited.

    3.38%

  • ClearBridge Advisors, LLC

    3.17%

  • ArrowMark Colorado Holdings, LLC (ArrowMark Partners)

    2.26%

Company Information

Doximity Inc is a US-based online networking company that launched in June 2010. It is a digital platform for all the leading healthcare professionals in the USA. The headquarters of Doximity Inc is in San Francisco, California. It is a public company traded as the DOCS at the New York Stock Exchange. Over 80% of all physicians in the USA across every specialty and practice area are registered on this platform. Its founders Jeff Tangney, Nate Gross, and Shari Buck, publicly launched the company in March 2011. By 2013, it became the largest network, with nearly 10% of US doctors as registered members. Doximity is known for providing verified memberships to healthcare professionals. It keeps them informed regarding the recent improvements in medicine, the latest inclusions, news, and research content. Moreover, the doctors can conduct virtual patient visits while collaborating with their colleagues anywhere in the country. It gained around 40% of the physicians as its members by 2014. In 2016, the company bagged 6th place in the Deloitte Technology Fast 500 list. They accounted that about 70% (1 million) US doctors registered on their platform. Currently Doximity, Inc. has a market cap of $3.0 Billion. It has a P.E ratio of 21.82. The shares of Doximity, Inc. are trading at $23.91. .

Organization
Doximity, Inc.
Employees
977
CEO
Mr. Jeffrey A. Tangney
Industry
Healthcare

Discover More

FAQs